UK scientists developing Ebola vaccine that could be ready for trials in months

“It is possible that these doses will be available for clinical trial within two to three months, but there is a lot of uncertainty,” a spokesperson added, and whether Bundibugyo can be considered a “promising candidate investigational vaccine” will depend on animal trials.